Exelon filed an 8‑K (Item 9.01) disclosing an Underwriting Agreement dated Feb 18, 2026 with BNP Paribas…
Filed with the SEC on · Summarized by InvestorsBot
Exelon filed an 8‑K (Item 9.01) disclosing an Underwriting Agreement dated Feb 18, 2026 with BNP Paribas Securities Corp., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC as lead reps — signals a debt offering; no principal amount/pricing disclosed. 🏦📄 $EXC #CapitalMarkets #Utilities
8‑K also attaches a Ninth Supplemental Indenture dated Feb 1, 2026 amending the June 11, 2015 indenture; The Bank of New York Mellon Trust Company, N.A. is trustee. Legal opinions from Ballard Spahr LLP are included. Signed Feb 20, 2026 by CFO Jeanne M. Jones. ✍️⚖️ $EXC #Debt
Filing contains standard forward‑looking statements and cautions. No use-of-proceeds, terms or pricing provided — investors should monitor upcoming pricing/prospectus filings and amendments for material details. 🔍📅 $EXC #Financing #Investing